Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
millions worldwide
injection |
| gptkbp:approvedBy |
gptkb:European_Medicines_Agency
gptkb:U.S._Food_and_Drug_Administration |
| gptkbp:availableOn |
September 2009
|
| gptkbp:contains |
inactivated H1N1 virus
live attenuated H1N1 virus |
| gptkbp:developedInResponseTo |
gptkb:2009_H1N1_influenza_pandemic
|
| gptkbp:distributionBegan |
October 2009
|
| https://www.w3.org/2000/01/rdf-schema#label |
2009 H1N1 vaccine
|
| gptkbp:includedIn |
2010 seasonal flu vaccine
|
| gptkbp:producedBy |
gptkb:Sanofi_Pasteur
gptkb:MedImmune gptkb:Novartis gptkb:CSL_Limited GlaxoSmithKline |
| gptkbp:recommendation |
children
pregnant women healthcare workers people with chronic health conditions |
| gptkbp:relatedTo |
seasonal influenza vaccine
|
| gptkbp:sideEffect |
fever
fatigue headache soreness at injection site |
| gptkbp:type |
monovalent vaccine
|
| gptkbp:usedFor |
prevention of 2009 H1N1 influenza
|
| gptkbp:bfsParent |
gptkb:2009_H1N1_pandemic
|
| gptkbp:bfsLayer |
5
|